Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

A promise is a promise.

¹Department of Health Behavior, Division of Cancer Prevention and Population Sciences, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, New York 14263, USA. michael.cummings@roswellpark.org

Tobacco Control

|May 30, 2003

Summary

Philip Morris previously pledged to cease cigarette production if their products proved harmful. Given their admission that smoking causes serious diseases like lung cancer and heart disease, this analysis questions when the company will fulfill its promise.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

E-cigarette Duration and Incident COPD Among Adults Aged 40 Years and Older with a Smoking History.

medRxiv : the preprint server for health sciences·2026

Same author

Reported exposure to E-cigarette advertising and promotion in different regulatory environments: Findings from the International Tobacco Control Four Country (ITC-4C) Survey.

Preventive medicine·2018

Same author

Impact of a community-wide stop smoking contest.

American journal of health promotion : AJHP·2011

Same author

Organizational factors affecting participation in a smoking cessation program and abstinence among 68 auto dealerships.

American journal of health promotion : AJHP·2011

Same author

Smokers' reactions to FDA regulation of tobacco products: findings from the 2009 ITC United States survey.

BMC public health·2011

Same author

The effects of extended pre-quit varenicline treatment on smoking behavior and short-term abstinence: a randomized clinical trial.

Clinical pharmacology and therapeutics·2011

Area of Science:

Public Health
Tobacco Control
Corporate Responsibility

Background:

Philip Morris International (PMI) has a documented history of public statements regarding the potential harms of smoking.
The tobacco industry has faced increasing scrutiny regarding the health consequences of its products.

Purpose of the Study:

To examine Philip Morris International's commitment to cease cigarette production.
To analyze the discrepancy between past promises and current business practices in light of scientific evidence.

Main Methods:

Review of public statements and corporate pledges made by Philip Morris International.
Analysis of scientific consensus on the health risks associated with smoking.
Comparison of stated commitments with ongoing tobacco product manufacturing.

Main Results:

Philip Morris International has publicly acknowledged that smoking causes lung cancer, heart disease, emphysema, and other serious health conditions.
Despite this admission, the company continues to manufacture and market conventional cigarettes.

Conclusions:

Philip Morris International's continued production of cigarettes contradicts its past promises to cease operations if harms were proven.
Urgent re-evaluation of corporate accountability and regulatory oversight is necessary in the tobacco industry.

Related Experiment Videos